Presentation TVT 2017 The Latest in TAVR Adjunctive Pharmacotherapy: The Case for Routine vs Selective Anticoagulant Therapy Presenter: George D. Dangas June 16, 2017
Presentation TVT 2017 A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors Presenter: Martin B. Leon June 16, 2017
Presentation TVT 2017 SURTAVI Vignette III: Subset Analysis of Strokes Presenter: A. Pieter Kappetein June 16, 2017
Presentation TVT 2017 SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients) Presenter: Jeffrey J. Popma June 16, 2017
Presentation TVT 2017 SURTAVI Vignette I: Applying Bayesian Methodology to Interventional Clinical Trials Presenter: David J. Cohen June 16, 2017
Presentation TVT 2017 Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients Presenter: Michael J. Reardon June 16, 2017
Presentation TVT 2017 Who Shouldnt Undergo TAVR? Can We Identify Non-responders? Presenter: Suzanne V. Arnold June 16, 2017
Presentation TVT 2017 Ineffective Endocarditis After TAVR: Cause for Concern? Presenter: Bernard Prendergast June 16, 2017
Presentation TVT 2017 Gender Differences in TAVR Outcomes Recent Analyses in Intermediate-Risk Patients Presenter: Molly Szerlip June 16, 2017